Cargando…
Antibiotic Management of Patients with Hematologic Malignancies: From Prophylaxis to Unusual Infections
PURPOSE OF REVIEW: Patients with hematological malignancies are recognized for their high susceptibility and increased risk of developing infections associated with immunosuppression that can be caused by the infection itself or by the treatments that condition a decrease in the humoral and T lympho...
Autores principales: | Moreno-Sanchez, Francisco, Gomez-Gomez, Brenda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938218/ https://www.ncbi.nlm.nih.gov/pubmed/35316843 http://dx.doi.org/10.1007/s11912-022-01226-y |
Ejemplares similares
-
Discontinuation of Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia: a Review of the Biological Factors Associated with Treatment-Free Remission
por: Stuckey, Ruth, et al.
Publicado: (2022) -
Managing the Risk of Infection in Chronic Lymphocytic Leukemia in the Era of New Therapies
por: Rivera, Daniel, et al.
Publicado: (2022) -
Access to Therapy for Acute Myeloid Leukemia in the Developing World: Barriers and Solutions
por: Meillon-Garcia, Luis Antonio, et al.
Publicado: (2020) -
Plasma Cell Leukemia: Definition, Presentation, and Treatment
por: Gundesen, Michael Tveden, et al.
Publicado: (2019) -
Revolution of Chronic Lymphocytic Leukemia Therapy: the Chemo-Free Treatment Paradigm
por: Scheffold, Annika, et al.
Publicado: (2020)